Cyclo Therapeutics, Inc. (CYTH)
0.7206
0.00 (0.00%)
Inactive · Last trade price on Mar 26, 2025

Cyclo Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
214512311941
Market Cap Growth
-277.44%-61.58%64.74%-53.83%-43.29%
Enterprise Value
32448231736
Last Close Price
0.721.591.423.734.3534.00

Price Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
PS Ratio
22.3842.238.7619.7721.0740.92
PB Ratio
-1.549.5616.402.001.8244.03
P/TBV Ratio
-9.5616.402.001.8244.03

EV Ratios

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
EV/Sales Ratio
36.7440.605.6414.5618.8136.02

Financial Efficiency

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Debt / Equity Ratio
-0.910.22-0.010.020.06
Asset Turnover
0.160.120.120.090.100.29
Inventory Turnover
0.340.390.620.720.310.72
Quick Ratio
0.061.110.464.473.520.93
Current Ratio
0.171.461.205.073.831.26
Return on Equity (ROE)
--730.48%-188.35%-109.37%-157.03%-781.18%
Return on Assets (ROA)
-284.27%-143.52%-82.27%-52.99%-61.21%-134.13%
Return on Invested Capital (ROIC)
--384.12%-117.80%-67.43%-96.27%-476.05%

Yields

Fiscal Year
CurrentFY 2023FY 2022FY 2021FY 2020FY 2019
Period Ending
Mar '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Earnings Yield
-119.73%-44.12%-128.28%-45.57%-46.99%-18.28%
FCF Yield
-108.72%-35.61%-125.62%-47.93%-45.16%-15.99%
Buyback Yield / Dilution
-109.38%-93.50%-32.48%-298.32%-47.81%-32.33%
SEC Filings: 10-K · 10-Q